{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:42Z","timestamp":1786112802381,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2025YC29"],"award-info":[{"award-number":["2025YC29"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304291"],"award-info":[{"award-number":["82304291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.drudis.2026.104638","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:54:48Z","timestamp":1773161688000},"page":"104638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic strategies for the fatty-acid-binding pocket of the spike protein: advances and perspectives"],"prefix":"10.1016","volume":"31","author":[{"given":"Wenwu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuona","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-5944","authenticated-orcid":false,"given":"Xiaocong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104638_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104638_b0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41422-021-00490-0","article-title":"Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2","volume":"31","author":"Yan","year":"2021","journal-title":"Cell Res"},{"key":"10.1016\/j.drudis.2026.104638_b0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41392-021-00653-w","article-title":"Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2026.104638_b0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV \u2013 a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104638_b0025","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02304-20","article-title":"Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects","volume":"95","author":"Nguyen","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2026.104638_b0030","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104638_b0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.drudis.2026.104638_b0040","doi-asserted-by":"crossref","DOI":"10.1177\/11779322211025876","article-title":"Structure and function of major SARS-CoV-2 and SARS-CoV proteins","volume":"15","author":"Gorkhali","year":"2021","journal-title":"Bioinform Biol Insights"},{"key":"10.1016\/j.drudis.2026.104638_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102619","article-title":"Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike","volume":"81","author":"Wrobel","year":"2023","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.drudis.2026.104638_b0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41579-025-01185-8","article-title":"SARS-CoV-2 spike protein: structure, viral entry and variants","volume":"23","author":"Chen","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104638_b0055","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104638_b0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104638_b0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104638_b0070","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.7326\/ANNALS-24-00464","article-title":"National Institutes of Health COVID-19 treatment guidelines panel: perspectives and lessons learned","volume":"177","author":"Gulick","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.drudis.2026.104638_b0075","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41467-022-28446-x","article-title":"Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoprotein","volume":"13","author":"Staufer","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104638_b0080","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/acscentsci.2c01190","article-title":"In silico discovery of small molecule modulators targeting the Achilles' heel of SARS-CoV-2 spike protein","volume":"9","author":"Wang","year":"2023","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.drudis.2026.104638_b0085","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/v14051080","article-title":"Palmitoylethanolamide (PEA) inhibits SARS-CoV-2 entry by interacting with S protein and ACE-2 receptor","volume":"14","author":"Fonnesu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2026.104638_b0090","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1038\/s41598-021-84850-1","article-title":"Polyunsaturated \u03c9-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry","volume":"11","author":"Goc","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104638_b0095","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41594-020-00549-3","article-title":"A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent","volume":"28","author":"Xiao","year":"2021","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.drudis.2026.104638_b0100","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.drudis.2026.104638_b0105","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1126\/science.abd3255","article-title":"Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein","volume":"370","author":"Toelzer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104638_b0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adc9179","article-title":"The free fatty acid-binding pocket is a conserved hallmark in pathogenic \u03b2-coronavirus spike proteins from SARS-CoV to Omicron","volume":"8","author":"Toelzer","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.drudis.2026.104638_b0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41586-020-2772-0","article-title":"Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion","volume":"588","author":"Benton","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104638_b0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.csbj.2021.12.011","article-title":"The fatty acid site is coupled to functional motifs in the SARS-CoV-2 spike protein and modulates spike allosteric behaviour","volume":"20","author":"Oliveira","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.drudis.2026.104638_b0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1107\/S2059798323000049","article-title":"Cryo-EM reveals binding of linoleic acid to SARS-CoV-2 spike glycoprotein, suggesting an antiviral treatment strategy","volume":"79","author":"Toelzer","year":"2023","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.drudis.2026.104638_b0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/v11010073","article-title":"Characterization of the lipidomic profile of human coronavirus-infected cells: implications for lipid metabolism remodeling upon coronavirus replication","volume":"11","author":"Yan","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2026.104638_b0135","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00194-21","article-title":"Cryo-electron microscopy structure of S-trimer, a subunit vaccine candidate for COVID-19","volume":"95","author":"Ma","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2026.104638_b0140","article-title":"Symptom duration shortened by early initiation of nebulized isomerized linoleic acid (LA) for outpatient treatment of COVID-19","author":"Jonsson","year":"2020","journal-title":"SSRN Electron J"},{"key":"10.1016\/j.drudis.2026.104638_b0145","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.1970.03180060075015","article-title":"Vitamin a physiology","volume":"214","author":"Roels","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2026.104638_b0150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJM199007193230304","article-title":"A randomized, controlled trial of vitamin A in children with severe measles","volume":"323","author":"Hussey","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2026.104638_b0155","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3390\/nu13072173","article-title":"Vitamin A plasma levels in COVID-19 patients: a prospective multicenter study and hypothesis","volume":"13","author":"Tepasse","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.drudis.2026.104638_b0160","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1126\/science.1136244","article-title":"A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A","volume":"315","author":"Kawaguchi","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104638_b0165","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1101\/gad.1533407","article-title":"RDH10 is essential for synthesis of embryonic retinoic acid and is required for limb, craniofacial, and organ development","volume":"21","author":"Sandell","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.drudis.2026.104638_b0170","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01485-22","article-title":"A retinol derivative inhibits SARS-CoV-2 infection by interrupting spike-mediated cellular entry","volume":"13","author":"Tong","year":"2022","journal-title":"MBio"},{"key":"10.1016\/j.drudis.2026.104638_b0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/ml2002482","article-title":"Discovery and development of potent LFA-1\/ICAM-1 antagonist SAR 1118 as an ophthalmic solution for treating dry eye","volume":"3","author":"Zhong","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.drudis.2026.104638_b0180","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03681-20","article-title":"Multidisciplinary approaches identify compounds that bind to human ACE2 or SARS-CoV-2 spike protein as candidates to block SARS-CoV-2-ACE2 receptor interactions","volume":"12","author":"Day","year":"2021","journal-title":"MBio"},{"key":"10.1016\/j.drudis.2026.104638_b0185","doi-asserted-by":"crossref","first-page":"13060","DOI":"10.1021\/jacs.2c05603","article-title":"NMR experiments provide insights into ligand-binding to the SARS-CoV-2 spike protein receptor-binding domain","volume":"144","author":"Creutznacher","year":"2022","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2026.104638_b0190","doi-asserted-by":"crossref","first-page":"10742","DOI":"10.1021\/acs.jmedchem.0c00523","article-title":"High-throughput screening for the discovery of enzyme inhibitors","volume":"63","author":"Lloyd","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104638_b0195","doi-asserted-by":"crossref","first-page":"0121","DOI":"10.1038\/s41570-018-0121","article-title":"Inverse design in search of materials with target functionalities","volume":"2","author":"Zunger","year":"2018","journal-title":"Nat Rev Chem"},{"key":"10.1016\/j.drudis.2026.104638_b0200","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1021\/acs.jcim.0c01496","article-title":"Generative deep learning for targeted compound design","volume":"61","author":"Sousa","year":"2021","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.drudis.2026.104638_b0205","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg7865","article-title":"Accelerating drug target inhibitor discovery with a deep generative foundation model","volume":"9","author":"Chenthamarakshan","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.drudis.2026.104638_b0210","article-title":"CogMol: target-specific and selective drug design for COVID-19 using deep generative models","volume":"2004","author":"Chenthamarakshan","year":"2020","journal-title":"arXiv"},{"key":"10.1016\/j.drudis.2026.104638_b0215","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1002\/anie.202015639","article-title":"Molecular simulations suggest vitamins, retinoids and steroids as ligands of the free fatty acid pocket of the SARS-CoV-2 spike protein","volume":"60","author":"Shoemark","year":"2021","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.drudis.2026.104638_b0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","article-title":"Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing","volume":"586","author":"Riva","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104638_b0225","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.3390\/ijms24044192","article-title":"Identifying SARS-CoV-2 drugs binding to the spike fatty acid binding pocket using in silico docking and molecular dynamics","volume":"24","author":"Piplani","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104638_b0230","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1021\/acsinfecdis.1c00278","article-title":"Antiviral potential of the antimicrobial drug atovaquone against SARS-CoV-2 and emerging variants of concern","volume":"7","author":"Carter-Timofte","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.drudis.2026.104638_b0235","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/bcpt.13537","article-title":"The tyrosine kinase inhibitor nilotinib inhibits SARS-CoV-2 in vitro","volume":"128","author":"Cagno","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.drudis.2026.104638_b0240","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75720","article-title":"The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein","volume":"11","author":"Dokainish","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2026.104638_b0245","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4103\/ijp.ijp_111_22","article-title":"Virtual screening and molecular dynamics simulation study of approved drugs as a binder to the linoleic acid binding site on spike protein of SARS-CoV-2 and double mutant (E484Q and L452R)","volume":"54","author":"Prajapat","year":"2022","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.drudis.2026.104638_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008489","article-title":"A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro","volume":"16","author":"Zhang","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.drudis.2026.104638_b0255","doi-asserted-by":"crossref","first-page":"24117","DOI":"10.1021\/acsomega.4c10519","article-title":"In silico discovery of a novel antiviral scaffold for SARS-CoV\u20112 targeting the spike glycoprotein through the fatty acid binding pocket","volume":"10","author":"Queir\u00f3s-Reis","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.drudis.2026.104638_b0260","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1038\/s41467-020-17796-z","article-title":"Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells","volume":"11","author":"Zhu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104638_b0265","article-title":"Dual-locking the SARS-CoV-2 spike trimer: an amphipathic molecular \u201cbolt\u201d stabilizes conserved druggable interfaces for coronavirus inhibition","volume":"12","author":"Li","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.drudis.2026.104638_b0270","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s13238-020-00768-w","article-title":"Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2","volume":"11","author":"Xiong","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.drudis.2026.104638_b0275","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0968-0004(98)01285-7","article-title":"Multiple sequence alignment with Clustal X","volume":"23","author":"Jeanmougin","year":"1998","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.drudis.2026.104638_b0280","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:14:39Z","timestamp":1785946479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1359644626000437"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104638","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic strategies for the fatty-acid-binding pocket of the spike protein: advances and perspectives","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104638"}}